PubMed Health⌕ Search

Biomedical subjects

H Martin Dietrich

Publications and source records attributed to H Martin Dietrich.

6 recordsLinked to original sources
PubMed2006

"Ionic carbenes": synthesis, structural characterization, and reactivity of rare-Earth metal methylidene complexes.

Treatment of mixed chloride tetramethylaluminate polynuclear clusters {Cp*Y[(mu-Me)2AlMe2](mu-Cl)}2 and {Cp*6La6[(mu-Me)3AlMe]4(mu3-Cl)2(mu2-Cl)6} with toluene/THF solutions produces "aluminum-free" methylidene complexes [Cp*3Ln3(mu-Cl)3(mu3-Cl)(mu3-CH2)(THF)3] (Ln = Y, La). The trinuclear methylidene complexes are isostructural in the solid state and feature a sterically well-shielded Schrock-type nucleophilic CH22- unit, which is prone to Tebbe-like methylenation reactions with ketones and aldehydes. The rapid polymerization of gamma-valerolactone reveals intrinsic rare-earth metal reactivity.

Journal Article↗
PubMed2006

Multiple C-H bond activation in group 3 chemistry: synthesis and structural characterization of an yttrium-aluminum-methine cluster.

Complete donor-induced alkylaluminate cleavage of halfmetallocene complex Cp*Y(AlMe4)2, that is, treatment of Cp*Y(AlMe4)2 with 2 equiv of diethyl ether, produces [Cp*Y(mu2-Me)2]3 in high yield (95%). In contrast, the equimolar reaction of Cp*Y(AlMe4)2 with diethyl ether reproducibly formed complex [Cp*4Y4(mu2-CH3)2{(CH3)Al(mu2-CH3)2}4(mu4-CH)2] in low yield (10-30%) via a multiple C-H bond activation. The synthesis of the heterooctametallic yttrium-aluminum-methine cluster was also accomplished in moderate yield (47%) by the equimolar reaction of discrete Cp*Y(AlMe4)2 and [Cp*Y(mu2-Me)2]3 in the absence of any donor solvent and "free" AlMe3. This gives strong evidence that preformed heterometal-bridged Y-CH3-Al moieties are prone to multiple hydrogen abstraction in the presence of a highly basic reagent such as [Cp*Y(mu2-Me)2]3. The monocylopentadienyl complexes [Cp*Y(mu2-Me)2]3 and [Cp*4Y4(mu2-CH3)2{(CH3)Al(mu2-CH3)2}4(mu4-CH)2] were structurally characterized.

Journal Article↗
PubMed2005

[LnIIAlIII2(alkyl)8]x: donor addition instead of donor-induced cleavage.

(SmAl2Me8)x and (SmAl2Et8)x are obtained via a silylamide elimination reaction from Sm[N(SiMe3)2]2(THF)2 and excess AlR3 (R = Me, Et); (LnAl2Et8)x (Ln = Sm, Yb) react with THF, pyridine, and 1,10-phenanthroline to form the first donor adducts of homoleptic peralkylated Ln-Al heterobimetallic complexes.

Journal Article↗